ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meeting Abstracts
    • All Meetings
    • ACR Convergence 2026
    • PRSYM 2026
    • ACR Convergence 2025
    • Download Abstract Supplements
  • Keyword Index
  • My Favorites
    • View & print my favorites
  • Search

Home » Meeting Abstracts » ACR/ARHP Annual Meeting 2014

Abstract Number: 2675

The Selective Loss of SLAMF4+ CD8+ T Cells Contributes to the Decreased Cytotoxic Capacity Observed in Systemic Lupus Erythematosus

Katalin Kis-Toth1, Denis Comte1, Maria Karampetsou1, Lakshmi Kannan2 and George C. Tsokos1, 1Rheumatology, Beth Israel Deaconess Medical Center/Harvard Medical School, Boston, MA, 2Rheumtology, Beth Israel Deaconess Medical Center/Harvard Medical School, Boston, MA

Share on X (Twitter) Share on Facebook Share on LinkedIn Share on Email
Print

Meeting: ACR/ARHP Annual Meeting 2014

Keywords: Systemic lupus erythematosus (SLE)

Session Information

Title: Systemic Lupus Erythematosus - Human Etiology and Pathogenesis: T and B Cell Signaling and Genetic Variants

Session Type: Abstract Submissions (ACR)

Background/Purpose

Signaling lymphocytic activation molecule family member 4 (SLAMF4) engagement by its ligand SLAMF2 can mediate the cytotoxicity of CD8+ T cells and natural killer cells. SLE CD8+ T lymphocytes are reportedly defective in cytotoxicity. The aim of this study was to investigate the expression and function of SLAMF4 on SLE CD8+ T cells.

Methods

The expression of SLAMF4 and its adaptor SAP in healthy and SLE T cells were measured by Q-PCR, flow cytometry and western blot. T cells were treated by immobilized anti-SLAMF4 antibodies and the cytotoxic capacity of the T cells was monitored by the cell surface expression of CD107a, reflecting exocytosis of lytic granules.

Results

We found significant downregulation of SLAMF4 and the adaptor molecule SAP gene and protein expression in SLE T cells compared to normal controls. Characterization of the T cell subsets revealed that SLE patients have significantly less SLAMF4+ CD8+ T cells compared to normal control T cells, switching the SLAMF4+/SLAMF4– ratio in the favor of SLAMF4– CD8+ T cells which have less SAP expression and decreased cytotoxic capacity. SLAMF4 engagement triggers the degranulation of CD8+ T cells and SLE T cells have decreased degranulation capacity compared to normal controls. In the effort to explain the loss of SLAMF4+ CD8+ T cells in SLE we found that these cells are more likely become double negative T cells and/or die by apoptosis. 

Conclusion

Based on our results we conclude that the selective loss of SLAMF4+ CD8+ T cells may contribute to the ineffective capacity of fighting against infections in SLE.


Disclosure:

K. Kis-Toth,
None;

D. Comte,
None;

M. Karampetsou,
None;

L. Kannan,
None;

G. C. Tsokos,
None.

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-selective-loss-of-slamf4-cd8-t-cells-contributes-to-the-decreased-cytotoxic-capacity-observed-in-systemic-lupus-erythematosus/

My Favorites

Save and print abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract (must have cookies enabled in browser). See saved favorites.

Abstract Policies

  • ACR Convergence Abstract Embargo Policies
  • ACR Convergence Abstract Permissions & Reprints
  • PRSYM Abstract Policies

ACR Convergence. Where Rheumatology Meets

ACR Convergence 2026

Join us November 6-11 in Orlando, Florida.
See Registration Information

  • Contact ACR
  • Privacy Policy
  • ACR Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology